COM:ACURAPHARM

Acura Pharmaceuticals, Inc.

Stock

Market Cap

303.61K

Beta: -

Volume Today

3

Avg: -

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
revenue	123K -	751K 510.57%	8.59M 1,043.41%	4.46M 48.01%	2.97M 33.56%	410K 86.18%	2.66M 548.05%	3.57M 34.36%	1.56M 56.22%
cost of revenue	114K -	227K 99.12%	656K 188.99%	451K 31.25%	128K 71.62%		1.50K -	1.78K 18.34%	1.21M 67,895.51%
gross profit	9K -	524K 5,722.22%	7.93M 1,413.55%	4.01M 49.40%	2.84M 29.28%	410K 85.55%	2.66M 547.68%	3.57M 34.37%	352K 90.14%
selling and marketing expenses
general and administrative expenses				6.52M -			1.88M -	2.55M 35.70%	1.25M 50.80%
selling general and administrative expenses	8.93M -	7.94M 11.05%	8.99M 13.27%	6.52M 27.55%	4.34M 33.36%	2.57M 40.90%	1.88M 26.85%	2.55M 35.70%	1.25M 50.80%
research and development expenses	4.92M -	4.58M 6.93%	2.61M 43.08%	4.03M 54.45%	3.72M 7.62%	1.76M 52.73%	1.50M 14.44%	1.78M 18.34%	1.52M 14.43%
other expenses			3K -	2K 33.33%		296K -
cost and expenses	13.96M -	12.95M 7.25%	12.59M 2.80%	11.02M 12.45%	8.19M 25.68%	4.33M 47.20%	3.38M 21.80%	4.33M 27.97%	2.78M 35.84%
operating expenses	13.85M -	12.72M 8.13%	11.93M 6.22%	10.57M 11.41%	8.06M 23.72%	4.33M 46.36%	3.38M 21.80%	4.33M 27.97%	2.78M 35.84%
interest expense	9K -	1.21M 13,366.67%	1.16M 4.54%	893K 22.82%	596K 33.26%	223K 62.58%	449K 101.35%	450K 0.22%	200K 55.56%
ebitda	-13.71M -	-12.20M 11.00%	-4.00M 67.23%	-6.55M 63.96%	-5.22M 20.35%	-3.62M 30.68%	-725K 79.97%	-633K 12.69%	-1.21M 91.79%
operating income	-14.09M -	-12.20M 13.42%	-4.00M 67.20%	-6.56M 63.88%	-5.22M 20.31%	-3.92M 25.07%	-725K 81.48%	-758K 4.55%	-1.21M 60.16%
depreciation and amortization	134K -	274K 104.48%	332K 21.17%	345K 3.92%	294K 14.78%	280K 4.76%	273K 2.50%	125K 54.21%	90K 28.00%
total other income expenses net	-52K -	202K 488.46%	169K 16.34%	62K 63.31%	-592K 1,054.84%	296K 150%	-3.05M 1,130.07%	-450K 85.24%	335K 174.44%
income before tax	-13.90M -	-13.21M 4.98%	-4.99M 62.23%	-7.39M 48.09%	-5.82M 21.26%	-3.84M 33.95%	-3.77M 1.77%	-1.21M 67.99%	-879K 27.24%
income tax expense	9K -	938K 10,322.22%	828K 11.73%	550K 33.57%	-135K 124.55%	468K 446.67%	176K 62.39%	450K 155.68%	200K 55.56%
net income	-13.90M -	-13.21M 4.98%	-4.99M 62.23%	-7.39M 48.09%	-5.68M 23.09%	-3.84M 32.38%	-3.95M 2.81%	-1.66M 58.03%	-1.08M 34.92%
weighted average shs out	9.55M -	9.78M 2.37%	10.80M 10.40%	11.87M 9.95%	15.90M 33.98%	21.15M 32.97%	26.72M 26.36%	32.32M 20.96%	56.80M 75.75%
weighted average shs out dil	9.55M -	9.78M 2.37%	10.80M 10.40%	11.87M 9.95%	15.90M 33.98%	21.15M 32.97%	26.72M 26.36%	32.32M 20.96%	56.80M 75.75%
eps	-1.46 -	-1.35 7.53%	-0.46 65.93%	-0.62 34.78%	-0.36 41.94%	-0.18 50%	-0.15 16.67%	-0.05 65.80%	-0.02 62.96%
epsdiluted	-1.46 -	-1.35 7.53%	-0.46 65.93%	-0.62 34.78%	-0.36 41.94%	-0.18 50%	-0.15 16.67%	-0.05 65.80%	-0.02 62.96%

All numbers in (except ratios and percentages)